Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

20.01
Delayed Data
As of May 26
 +0.04 / +0.20%
Today’s Change
12.25
Today|||52-Week Range
33.74
+10.37%
Year-to-Date

Today’s Trading

Previous close19.97
Today’s open20.19
Day’s range19.56 - 20.34
Volume1,150,827
Average volume (3 months)2,041,176
Market cap$1.2B
Dividend yield--
Data as of 4:00pm ET, 05/26/2016

Growth & Valuation

Earnings growth (last year)-161.46%
Earnings growth (this year)+70.76%
Earnings growth (next 5 years)+24.00%
Revenue growth (last year)-12.20%
P/E ratioNM
Price/Sales3.18
Price/Book3.88

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd-0.25-0.90%
DNAIProNAi Therapeutics ...+0.28+4.58%
OASMOasmia Pharmaceutica...-0.18-3.70%
NEPTNeptune Technologies...+0.03+2.61%
Data as of 4:00pm ET, 05/26/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)$0.27
Annual revenue (last year)$342.7M
Annual profit (last year)-$75.7M
Net profit margin-22.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
CFO, Senior VP &
Head-Investor Relations
August J. Moretti
Corporate headquarters
Newark, California

Forecasts

Partner Offers

Search for Jobs